Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The bottom line Liraglutide is a GLP-1 medication approved for both weight loss (as the brand name Saxenda) and diabetes (as the brand name Victoza)
Stay ahead of the science
Strategic protein intake and creatine supplementation to preserve muscle during GLP-1 treatment can significantly improve body composition outcomes
Heres how it contributes to weight loss: Appetite Suppression: It reduces hunger, making it easier to eat less
People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open
Nausea, vomiting, and other gastrointestinal symptoms are common, particularly when starting or increasing the dose and in T1D trials, these rates were similar to those seen in T2D and obesity trials
US$ 20.99
US$ 22.68
US$ 20.30
US$ 21.05
